Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis

Author:

Collorone Sara1ORCID,Coll Llucia2,Lorenzi Marco3,Lladó Xavier4ORCID,Sastre-Garriga Jaume2ORCID,Tintoré Mar2ORCID,Montalban Xavier2,Rovira Àlex56ORCID,Pareto Deborah56,Tur Carmen12ORCID

Affiliation:

1. NMR Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK

2. Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

3. Epione Research Project, Inria Sophia Antipolis, Université Côte d’Azur, Nice, France

4. Research Institute of Computer Vision and Robotics, University of Girona, Girona, Spain

5. Section of Neuroradiology, Department of Radiology (IDI), Vall d’Hebron University Hospital, Barcelona, Spain

6. Universitat Autònoma de Barcelona, Barcelona, Spain

Abstract

Artificial intelligence (AI) is the branch of science aiming at creating algorithms able to carry out tasks that typically require human intelligence. In medicine, there has been a tremendous increase in AI applications thanks to increasingly powerful computers and the emergence of big data repositories. Multiple sclerosis (MS) is a chronic autoimmune condition affecting the central nervous system with a complex pathogenesis, a challenging diagnostic process strongly relying on magnetic resonance imaging (MRI) and a high and largely unexplained variability across patients. Therefore, AI applications in MS have the great potential of helping us better support the diagnosis, find markers for prognosis to eventually design more powerful randomised clinical trials and improve patient management in clinical practice and eventually understand the mechanisms of the disease. This topical review aims to summarise the recent advances in AI applied to MRI data in MS to illustrate its achievements, limitations and future directions.

Funder

MAGNIMS

National Multiple Sclerosis Society

European Committee for Treatment and Research in Multiple Sclerosis

Institució Catalana de Recerca i Estudis Avançats

Novartis

Agence Nationale de la Recherche

Rosetrees Trust

Ministerio de Ciencia e Innovación

Instituto de Salud Carlos III

'la Caixa' Foundation

Fundación Merck Salud

Multiple Sclerosis Society

Roche

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3